— Know what they know.
Not Investment Advice

INVA NASDAQ

Innoviva, Inc.
1W: -2.9% 1M: -5.5% 3M: -5.1% YTD: +11.7% 1Y: +18.2% 3Y: +67.5% 5Y: +72.5%
$22.46
+0.26 (+1.17%)
 
Weekly Expected Move ±3.1%
$21 $21 $22 $23 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $1.7B mcap · 69M float · 1.05% daily turnover · Short 44% of daily vol

Cash Flow Trends

Operating Cash Flow
$197M +4.4% ▲
5Y CAGR: -8.9%
Capital Expenditures
$1M -318.9% ▼
5Y CAGR: +144.3%
Free Cash Flow
$196M +3.9% ▲
5Y CAGR: -9.0%
Dividends Paid
$0 +0.0% ▲
Buybacks
$5M +68.7% ▲
Net Change in Cash
$246M +120.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$369M$220M$180M$23M$271M
Depreciation & Amort.$14M$20M$36M$40M$40M
Stock-Based Comp.$2M$7M$6M$6M$9M
Change in Working Capital-$17M$7M-$25M-$7M-$24M
Other Non-Cash Items-$80M-$77M-$60M$139M-$144M
Operating Cash Flow$364M$202M$141M$189M$197M
— Investing Activities —
Capital Expenditures-$1M-$67K-$411K-$270K-$1M
Acquisitions (Net)-$236M-$33M$0$0$0
Investment Purchases$22M-$23M-$139M-$135M$14M
Investment Sales$280M$57M$72M$76M$28M
Other Investing-$21M-$57M$0-$4M-$929K
Investing Cash Flow$44M-$57M-$67M-$64M$40M
— Financing Activities —
Net Debt Issuance$0$66M-$96M$0-$25K
Stock Repurchased-$394M-$9M-$76M-$15M-$5M
Dividends Paid$0$0$0$0$0
Other Financing-$59M-$113M$0$0$0
Financing Cash Flow-$452M-$56M-$172M-$13M$9M
Net Change in Cash-$45M$90M-$98M$111M$246M
Cash End of Period$202M$291M$194M$305M$551M
Free Cash Flow$363M$202M$141M$188M$196M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms